Cyclerion Therapeutics (CYCN) Total Current Liabilities (2018 - 2025)

Cyclerion Therapeutics has reported Total Current Liabilities for 8 years, with the latest figure at $900000.0 in Q4 2025.

• On a quarterly basis, Total Current Liabilities rose 24.14% year-over-year to $900000.0 in Q4 2025; TTM through Dec 2025 was $900000.0, a 24.14% increase from a year earlier, with the FY2025 full-year figure at $900000.0, up 24.14% from the prior year.
• Total Current Liabilities was $900000.0 for Q4 2025 at Cyclerion Therapeutics, up from $877000.0 in the prior quarter.
• The five-year high for Total Current Liabilities was $13.5 million in Q1 2021, with the low at $700000.0 in Q3 2024.
• Average Total Current Liabilities over 5 years is $5.3 million, with a median of $3.6 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Total Current Liabilities plunged 80.87% in 2024, then advanced 25.29% in 2025.
• Over 5 years, Total Current Liabilities stood at $11.1 million in 2021, then plunged by 31.2% to $7.6 million in 2022, then tumbled by 72.65% to $2.1 million in 2023, then sank by 65.24% to $725000.0 in 2024, then rose by 24.14% to $900000.0 in 2025.
• The last three Total Current Liabilities figures came in at $900000.0 (Q4 2025), $877000.0 (Q3 2025), and $800000.0 (Q2 2025), per Business Quant data.